EUVIMEDEUVIMED entdecken
Crossref

The Role of Anti‐Phosphatidylserine/Prothrombin Antibodies and the Lectin Complement Pathway in Anti‐Phospholipid Antibody‐Associated Preterm Delivery

Arianna Da Via iD, Maria O Borghi, Laura Trespidi, Lucia M Ghezzi, Caterina Bodio, Claudia Grossi, Erika Carbone, Elena Raschi, Roberta Erra, Nicoletta Di Simone, Maria Gerosa, Federica G Gazzola und 10 weitere

Arthritis & Rheumatology · 20.07.2026

DOI: 10.1002/art.70273 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Arthritis & Rheumatology, online erschienen am 20.07.2026. Verfasst von Arianna Da Via und 21 weiteren Autor:innen. Beteiligte Einrichtung: Laboratory of ImmunoRheumatologic Researches, IRCCS Istituto Auxologico Italiano, Milan, Italy. Die Arbeit nennt 44 Literaturangaben. Gefördert von: Ministero della Salute.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objective

Antiphospholipid antibodies (aPL) may directly affect placentation and trigger local complement‐mediated inflammation/thrombosis. Obstetric complications in the antiphospholipid syndrome (APS) are still frequent despite therapy/close monitoring, and the identification of new risk biomarkers is an unmet need. We aimed to prospectively investigate the prognostic value of classification/nonclassification laboratory APS criteria and markers of complement activation for pregnancy complications, in particular preterm delivery (PTD).

Methods

We observed 60 women prospectively during pregnancy and postpartum: 33 aPL‐positive (20 APS and 13 aPL‐carriers) and 27 aPL‐negative (5 systemic lupus erythematosus, 11 rheumatoid arthritis and 11 undifferentiated connective tissue diseases). aPL criteria tests, anti‐phosphatidylserine/prothrombin (anti‐PS/PT) IgG/IgM and anti‐β2glycoprotein I‐Domain I IgG, complement products (C3, C4, C3a, C5a, sC5b‐9, MBL) and complement pathway activity (classical pathway [CP], alternative pathway [AP], and lectin pathway [LP]) were measured in 231 available specimens.

Results

PTD was experienced in 21% of aPL‐positive and 15% of aPL‐negative women. Anti‐PS/PT IgG/IgM titers were significantly higher in PTD versus non‐PTD women ( P < 0.05) at almost all time points. At variance with CP and AP, LP activity in aPL‐positive PTD was lower than in non‐PTD, reaching a statistically significant difference compared with aPL‐negative PTD patients ( P < 0.05). Moreover, LP activity significantly correlated with anti‐PS/PT IgG/IgM titers, both measured in the first trimester ( P < 0.05), and all of them significantly correlated with the week of gestation at delivery ( P < 0.05).

Conclusion

The reduced LP activity and the higher anti‐PS/PT IgG/IgM titers in PTD aPL‐positive women during the first trimester suggest their use as early prognostic tools for PTD in aPL‐positive pregnant women. image

Autor:innen und Institutionen

  • Laboratory of ImmunoRheumatologic Researches, IRCCS Istituto Auxologico Italiano, Milan, Italy.
  • Dipartimento di Scienze Cliniche e di Comunità, Dipartimento di Eccellenza 2023 to 2027, University of Milan, Milan, Italy.
  • S.C. Ostetricia, Foundation IRCCS Ca' Granda Ospedale Maggiore Policlinico, Milan, Italy.
  • Department of Brain and Behavioral Sciences, University of Pavia, Pavia, Italy.
  • Department of Biomedical Sciences, Humanitas University, Milan, Italy.
  • IRCCS Humanitas Research Hospital, Milan, Italy.

ORCID-Profile: Arianna Da Via, Paola A Lonati

Förderung

  • Ministero della Salute

Zitieren

APA

Da Via, A., Borghi, M. O., Trespidi, L., Ghezzi, L. M., Bodio, C., Grossi, C., Carbone, E., Raschi, E., Erra, R., Di Simone, N., Gerosa, M., Gazzola, F. G., Locati, F., Caporali, R. F., Cetin, I., Lubrano, C., Bulla, R., Agostinis, C., Pegoraro, S., …, & Lonati, P. A. (2026). The Role of Anti‐Phosphatidylserine/Prothrombin Antibodies and the Lectin Complement Pathway in Anti‐Phospholipid Antibody‐Associated Preterm Delivery. Arthritis & Rheumatology. https://doi.org/10.1002/art.70273

Vancouver

Da Via A, Borghi MO, Trespidi L, Ghezzi LM, Bodio C, Grossi C, et al. The Role of Anti‐Phosphatidylserine/Prothrombin Antibodies and the Lectin Complement Pathway in Anti‐Phospholipid Antibody‐Associated Preterm Delivery. Arthritis & Rheumatology. 2026. doi:10.1002/art.70273

BibTeX
@article{DaVia2026,
  author = {Da Via, Arianna and Borghi, Maria O and Trespidi, Laura and Ghezzi, Lucia M and Bodio, Caterina and Grossi, Claudia and Carbone, Erika and Raschi, Elena and Erra, Roberta and Di Simone, Nicoletta and Gerosa, Maria and Gazzola, Federica G and Locati, Federica and Caporali, Roberto F and Cetin, Irene and Lubrano, Chiara and Bulla, Roberta and Agostinis, Chiara and Pegoraro, Silvia and Tedesco, Francesco and Meroni, PierLuigi and Lonati, Paola A},
  title = {The Role of Anti‐Phosphatidylserine/Prothrombin Antibodies and the Lectin Complement Pathway in Anti‐Phospholipid Antibody‐Associated Preterm Delivery},
  journal = {Arthritis & Rheumatology},
  year = {2026},
  doi = {10.1002/art.70273}
}
Kostenlos starten →